Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2026-04-17 @ 5:58 AM
Study NCT ID:
NCT06187961
Status:
RECRUITING
Last Update Posted:
2024-12-12
First Post:
2023-12-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
Sponsor:
Tongji Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2023-S039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |